354 related articles for article (PubMed ID: 29656849)
21. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
Assefa A; Gelaw B; Getnet G; Yitayew G
BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
[TBL] [Abstract][Full Text] [Related]
22. Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy.
Westreich DJ; Sanne I; Maskew M; Malope-Kgokong B; Conradie F; Majuba P; Funk MJ; Kaufman JS; Van Rie A; Macphail P
Clin Infect Dis; 2009 Jun; 48(11):1617-23. PubMed ID: 19385733
[TBL] [Abstract][Full Text] [Related]
23. Incidence and predictors of extrapulmonary tuberculosis among people living with Human Immunodeficiency Virus in Addis Ababa, Ethiopia: A retrospective cohort study.
Alemu A; Yesuf A; Gebrehanna E; Zerihun B; Getu M; Worku T; Bitew ZW
PLoS One; 2020; 15(5):e0232426. PubMed ID: 32374773
[TBL] [Abstract][Full Text] [Related]
24. Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.
Said K; Verver S; Kalingonji A; Lwilla F; Mkopi A; Charalambous S; Reither K
Afr Health Sci; 2017 Mar; 17(1):208-215. PubMed ID: 29026395
[TBL] [Abstract][Full Text] [Related]
25. Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections.
Dronda F; Sobrino P; Hernández-Novoa B; Caro-Murillo AM; Montero M; Iribarren JA; Sanz J; Del Mar Alonso M; Labarga P; Bernal E; Moreno S;
Curr HIV Res; 2011 Jun; 9(4):229-36. PubMed ID: 21631429
[TBL] [Abstract][Full Text] [Related]
26. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort study.
Maruza M; Albuquerque MF; Coimbra I; Moura LV; Montarroyos UR; Miranda Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
BMC Infect Dis; 2011 Dec; 11():351. PubMed ID: 22176628
[TBL] [Abstract][Full Text] [Related]
28. High rates of tuberculosis in patients accessing HAART in rural South Africa.
Naidoo K; Karim QA; Bhushan A; Naidoo K; Yende-Zuma N; McHunu PK; Frohlich J; Karim F; Upfold M; Kocheleff P; Abdool Karim SS
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):438-46. PubMed ID: 24256629
[TBL] [Abstract][Full Text] [Related]
29. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
[TBL] [Abstract][Full Text] [Related]
30. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.
Lawn SD; Myer L; Edwards D; Bekker LG; Wood R
AIDS; 2009 Aug; 23(13):1717-25. PubMed ID: 19461502
[TBL] [Abstract][Full Text] [Related]
31. Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment.
Pettit AC; Mendes A; Jenkins C; Napravnik S; Freeman A; Shepherd BE; Dowdy D; Gill J; Rachlis A; Moore R; Sterling TR;
J Acquir Immune Defic Syndr; 2016 Aug; 72(5):572-8. PubMed ID: 27049511
[TBL] [Abstract][Full Text] [Related]
32. Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008.
Auld AF; Mbofana F; Shiraishi RW; Alfredo C; Sanchez M; Ellerbrock TV; Nelson LJ
PLoS One; 2013; 8(1):e54665. PubMed ID: 23349948
[TBL] [Abstract][Full Text] [Related]
33. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.
Girardi E; Palmieri F; Cingolani A; Ammassari A; Petrosillo N; Gillini L; Zinzi D; De Luca A; Antinori A; Ippolito G
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):326-31. PubMed ID: 11317073
[TBL] [Abstract][Full Text] [Related]
34. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
[TBL] [Abstract][Full Text] [Related]
35. Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
Kwara A; Carter EJ; Rich JD; Flanigan TP
AIDS Patient Care STDS; 2004 Jun; 18(6):341-7. PubMed ID: 15294084
[TBL] [Abstract][Full Text] [Related]
36. Incidence of cardiovascular diseases in a nationwide HIV/AIDS patient cohort in Taiwan from 2000 to 2014.
Lai YJ; Chen YY; Huang HH; Ko MC; Chen CC; Yen YF
Epidemiol Infect; 2018 Dec; 146(16):2066-2071. PubMed ID: 30157970
[TBL] [Abstract][Full Text] [Related]
37. Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.
Grinsztejn B; Veloso VG; Pilotto JH; Campos DP; Keruly JC; Moore RD
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):515-20. PubMed ID: 17558332
[TBL] [Abstract][Full Text] [Related]
38. Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
Pathmanathan I; Dokubo EK; Shiraishi RW; Agolory SG; Auld AF; Onotu D; Odafe S; Dalhatu I; Abiri O; Debem HC; Bashorun A; Ellerbrock T
PLoS One; 2017; 12(3):e0173309. PubMed ID: 28282390
[TBL] [Abstract][Full Text] [Related]
39. Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.
Girardi E; Sabin CA; d'Arminio Monforte A; Hogg B; Phillips AN; Gill MJ; Dabis F; Reiss P; Kirk O; Bernasconi E; Grabar S; Justice A; Staszewski S; Fätkenheuer G; Sterne JA;
Clin Infect Dis; 2005 Dec; 41(12):1772-82. PubMed ID: 16288403
[TBL] [Abstract][Full Text] [Related]
40. Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study.
Arefaine ZG; Abebe S; Bekele E; Adem A; Adama Y; H Brockmeyer N; Coenenberg J; Potthoff A; Gebremeskel TG
PLoS One; 2020; 15(4):e0229757. PubMed ID: 32310961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
